These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38798862)

  • 1. Correlation between circulating fibrosis biomarkers with left atrial function and left atrial volume index in rheumatic mitral stenosis.
    Asrial AA; Reviono R; Soetrisno S; Setianto BY; Widyaningsih V; Nurwati I; Wasita B; Pudjiastuti A
    Narra J; 2024 Apr; 4(1):e293. PubMed ID: 38798862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation.
    Meel R; Nethononda R; Libhaber E; Dix-Peek T; Peters F; Essop M
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):150-154. PubMed ID: 29443354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease.
    Banerjee T; Mukherjee S; Ghosh S; Biswas M; Dutta S; Pattari S; Chatterjee S; Bandyopadhyay A
    PLoS One; 2014; 9(3):e90527. PubMed ID: 24603967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between mitral valve area and left atrial function in rheumatic mitral valve stenosis patients.
    Fareed A; Hamed M; Makaldy F; Saleh O
    Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):292-298. PubMed ID: 36594849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Dapagliflozin on Patients with Rheumatic Heart Disease Mitral Stenosis.
    Asrial AA; Reviono R; Soetrisno S; Setianto BY; Widyaningsih V; Nurwati I; Wasita B; Pudjiastuti A
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrillatory wave amplitude as a marker of left atrial and left atrial appendage function, and a predictor of thromboembolic risk in patients with rheumatic mitral stenosis.
    Mutlu B; Karabulut M; Eroglu E; Tigen K; Bayrak F; Fotbolcu H; Basaran Y
    Int J Cardiol; 2003 Oct; 91(2-3):179-86. PubMed ID: 14559128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease.
    Sun Y; Huang ZY; Wang ZH; Li CP; Meng XL; Zhang YJ; Su F; Ma N
    Mol Cell Biochem; 2015 Aug; 406(1-2):131-8. PubMed ID: 25971370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT-ProBNP as a Potential Marker of Left Atrial Dysfunction in Rheumatic Mitral Stenosis: Correlation with Left Atrial Function after PBMV.
    Khare R; Dwivedi S
    J Heart Valve Dis; 2016 Sep; 25(5):613-618. PubMed ID: 28238244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
    Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
    Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between New York functional class and duke activity status index with the severity of mitral valve stenosis and echocardiographic parameters: is left atrial strain a better predictor?
    Bigdelu L; Alimi H; Poorzand H; Ghaderi F; Afshar S; Rafighdoost AH; Baradaran Rahimi V
    Int J Cardiovasc Imaging; 2024 May; 40(5):1115-1122. PubMed ID: 38589678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the CHA2DS2-VASc score with left atrial spontaneous echo contrast: a cross-sectional study of patients with rheumatic mitral stenosis in sinus rhythm.
    Belen E; Ozal E; Pusuroglu H
    Heart Vessels; 2016 Sep; 31(9):1537-43. PubMed ID: 26475711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial longitudinal strain parameters predict left atrial reverse remodeling after mitral valve surgery: a speckle tracking echocardiography study.
    Candan O; Ozdemir N; Aung SM; Hatipoglu S; Karabay CY; Guler A; Gecmen C; Dogan C; Omaygenc O; Bakal RB
    Int J Cardiovasc Imaging; 2014 Aug; 30(6):1049-56. PubMed ID: 24781032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort.
    Kobayashi M; Ferreira JP; Duarte K; Bresso E; Huttin O; Bozec E; Brunner La Rocca HP; Delles C; Clark AL; Edelmann F; González A; Heymans S; Pellicori P; Petutschnigg J; Verdonschot JAJ; Rossignol P; Cleland JGF; Zannad F; Girerd N;
    Eur J Heart Fail; 2024 May; 26(5):1231-1241. PubMed ID: 38528728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment of left atrial fibrosis. Correlation between echocardiography, biomarkers, and electroanatomical mapping.
    Pilichowska-Paszkiet E; Baran J; Sygitowicz G; Sikorska A; Stec S; Kułakowski P; Zaborska B
    Echocardiography; 2018 Sep; 35(9):1326-1334. PubMed ID: 29900593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial mechanical dispersion and left atrial stiffness predicts recurrence of atrial fibrillation: In patients with moderate-severe rheumatic mitral stenosis.
    Liu T; Yang X; Jia R; Han J; Gu X; Liu P; Zhang Y; Jiang W; Hao X; He Y
    Int J Cardiol; 2024 Dec; 416():132480. PubMed ID: 39197727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage flow velocity and spontaneous echo contrast in patients with rheumatic mitral stenosis: a multiplane transesophageal echocardiographic study.
    Ho HY; Wang KY; Ting CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Dec; 56(6):380-5. PubMed ID: 8851478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated fibrinogen and lowered homocysteine-vitamin determinants and their association with left atrial thrombus in patients with rheumatic mitral stenosis.
    Murugesan V; Pulimamidi VK; Rajappa M; Satheesh S; Revathy G; Harichandrakumari KT
    Br J Biomed Sci; 2015; 72(3):102-6. PubMed ID: 26510264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
    Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance and Expressions of MMP-1, TIMP-1 and TGF-β1 in Valve Tissue of Rheumatic Heart Disease].
    Yu Y; Li ZQ; Chen K; Zhan P; Liao J; Ruan QY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):52-56. PubMed ID: 28612558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Matrix Metalloproteinases and Left Atrial Remodeling-The Hoorn Study.
    Linssen PBC; Brunner-La Rocca HP; Schalkwijk CG; Beulens JWJ; Elders PJM; van der Heijden AA; Slieker RC; Stehouwer CDA; Henry RMA
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.